“…All bridging stents E-Ventus BX stent grafts remained patent (78 out of 82, 95.1%). Conclusion: E-Ventus BX stent grafts used as bridging stents during FEVAR and the IBD are associated with favourable outcomes at the mid-term follow-up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background: Many specialty drugs have lost patent exclusivity and more specialty generics (SGs) are expected in the future. …”
Enlace del recurso
Enlace del recurso

“…Angiography showed severe three-vessel disease with occlusion of a saphenous vein graft (SVG) to the first diagonal branch but patents grafts to left artery descendent (LIMA) and SVG to the right coronary artery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: The Target Selector ctDNA assay applies a patented Switch-Blocker technology to suppress amplification of background (wild-type) WT alleles, while allowing specific amplification of very low frequency mutant alleles. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The TCM treatment consisted of several patented Chinese medicines and TCM decoctions. The Western medication comprised mainly antibiotics, alpha receptor antagonists, and muscarinic receptor antagonists. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This retrospective cohort study included adult patients followed in a single-center predialysis clinic between 1999 and 2016. Patients with a patent AVF were followed up to 2 years pre- and post-AVF creation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: The objective is to describe characteristics of patients diagnosed with patulous Eustachian tube (PET) using the Diagnostic Criteria proposed by Japan Otological Society, and to evaluate the efficiency of objective tests to determine patent Eustachian tube. STUDY DESIGN: Retrospective. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Results: In Loeys-Dietz compared to Marfan syndrome, a patent ductus arteriosus (p = 0.014) was more prevalent, the craniofacial score was higher (p < 0.001), the systemic score lower (p < 0.001), and mitral valve prolapse less frequent (p = 0.003). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background and Objective: Qing-Kai-Ling (QKL) is derived from a famous ancient Chinese patent medicine Angong Niuhuang pills (ANP) which has been used across Asia, especially in China, for the treatment of “febrile disease,” such as stroke, encephalitis and meningitis for hundreds of years. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We have developed a new photosensitizer (PS-FOL/PS2), protected by a recently published patent (WO2019 016397-A1, 24 January 2019). This photosensitizer is associated with an addressing molecule (folic acid) targeting the folate receptor 1 (FOLR1) with a high affinity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Objective: Compound Kushen injection (CKI), one of the commonly used antitumor Chinese patent medicines, has been widely prescribed as adjunctive treatment to platinum-based chemotherapy (PBC) in patients with advanced non-small cell lung cancer (NSCLC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Moreover, 29 patients (54.7%) had ventricular septal defects (VSDs), 17 (32.1%) had atrial septal defects, 10 had patent ductus arteriosus (PDA), and 7 (13.2%) had Ebstein’s anomaly and double outlet right ventricle. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We have developed a method, called REMOBI (patent US8851669, WO2011073288) that allows us to test eye movements in three-dimensional space without decoupling vergence and accommodation.[1]. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Applications[[Unsupported Character - Symbol Font •]] Diagnosis of thyroid cancer from FNA samples[[Unsupported Character - Symbol Font •]] Predictive tool of severity of disease Advantages[[Unsupported Character - Symbol Font •]] Microenvironment profiling can provide a unique way to diagnose and assess disease progression[[Unsupported Character - Symbol Font •]] Sheds light on cellular cross-talk; more accurate diagnose; can prevent unnecessary surgery IP Status:​Patent Pending…”
Enlace del recurso
Enlace del recurso

“…We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalensis Georgi (Huang Qin), geniposide from Gardenia jasminoides J. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Other accompanying cardiac anomalies simultaneously repaired included ventricular septal defect and patent ductus arteriosus. All patients received 1.5-10 years of postoperative echocardiographic follow-up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The USPTO-380K and the USPTO-50K (which was also used by Liu et al.) were originally derived from Lowe’s patent mining work. Liu et al. further processed these data and divided the reaction examples into 10 categories, but we did not. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The results showed that compared to nCABG patents, pCABG patients were associated with lower technical success (82.3% versus 87.8%; OR, 0.60; 95% CI, 0.53–0.68; P < .00001; I(2) = 0%) and procedural success (80.4% versus 86.2%; OR, 0.61; 95% CI, 0.53–0.70; P < .00001; I(2) = 10%); a higher risk of all-cause mortality (OR, 2.95; 95% CI, 1.56–5.57; P = 0.0008; I(2) = 0%), MI (OR, 2.30; 95% CI, 1.40–3.80; P = .001; I(2) = 5%), and coronary perforation (OR, 2.16; 95% CI, 1.51–3.08; P < 0.0001; I(2) = 52%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Non-enzymatically isolated primary dermal progenitor fibroblasts (FE002-SK2 cell type) served for the establishment of a clinical-grade Parental Cell Bank, based on a patented method. Optimized bioprocessing methodology for the FE002-SK2 cell type has demonstrated that extensive and consistent progenitor cell banks can be established. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This work demonstrates that Phoenix(TM) (patent pending) is a superior mechanism for transporting living cells compared to the standard method of shipping frozen cells on dry ice (−80°C) or in liquid nitrogen (−150°C), which are destructive to the biology as well as a time consuming process. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso